RE:RE:RE:RE:RE:More volume on the tltff---usa--There is nothing wrong with oncologists studying TLT's Act, being impressed by it's potential and becoming stock holders, even if they are treating patients with it. I already know of 3 oncologists that are stock holders.
What might be "material" and prohibited might be if a doctor was treating the patient with the TLT ACT and knew the outcome of it and no one else did, but that is a ways down the road from where we are.